Effect of Cobicistat on Glomerular Filtration Rate in Subjects With Normal and Impaired Renal Function
Tóm tắt
Từ khóa
Tài liệu tham khảo
Stevens, 2006, . Assessing kidney functionmeasured and estimated glomerular filtration rate., N Engl J Med, 354, 2473, 10.1056/NEJMra054415
Luke, 1990, . Validity of creatinine clearance estimates in the assessment of renal function., Clin Pharmacol Ther, 48, 503, 10.1038/clpt.1990.186
Tett, 2003, . Principles and clinical application of assessing alterations in renal elimination pathways., Clin Pharmacokinet, 42, 1193, 10.2165/00003088-200342140-00002
Perrone, 1992, Serum creatinine as an index of renal function: new insights into old concepts., Clin Chem, 38, 1933, 10.1093/clinchem/38.10.1933
Brater, 2002, Measurement of renal function during drug development., Br J Clin Pharmacol, 54, 87, 10.1046/j.1365-2125.2002.01625.x
Levey, 1990, Measurement of renal function in chronic renal disease., Kidney Int, 38, 167, 10.1038/ki.1990.182
Berglund, 1975, Effect of trimethoprim-sulfamethoxazole on the renal excretion of creatinine in man., J Urol, 114, 802, 10.1016/S0022-5347(17)67149-0
Burgess, 1982, . Inhibition of renal creatinine secretion by cimetidine in humans., Ren Physiol, 5, 27
Opravil, 1993, Pyrimethamine inhibits renal secretion of creatinine., Antimicrob Agents Chemother, 37, 1056, 10.1128/AAC.37.5.1056
Andreev, 1999, A rise in plasma creatinine that is not a sign of renal failure: which drugs can be responsible J Intern Med., , 246, 247
Ixkes, 1997, . Cimetidine improves GFR-estimation by the Cockcroft and Gault formula., Clin Nephrol, 47, 229
Kabat-Koperska, 2007, Golembiewska E, et al.., Creatinine clearance after cimetidine administration: is it useful in the monitoring of the function of transplanted kidney Ren Fail, 29, 667
Kemperman, 1998, . Estimation of the glomerular filtration rate in NIDDM patients from plasma creatinine concentration after cimetidine administration., Diabetes Care, 21, 216, 10.2337/diacare.21.2.216
Cohen, 2011, . Randomized, phase 2 evaluation of two single-tablet regimens elvitegravircobicistatemtricitabinetenofovir disoproxil fumarate versus efavirenzemtricitabinetenofovir disoproxil fumarate for the initial treatment of HIV infection., AIDS, 25, F7, 10.1097/QAD.0b013e328345766f
Elion, 2011, . Phase 2 study of cobicistat versus ritonavir each with once-daily atazanavir and fixed-dose emtricitabinetenofovir df in the initial treatment of HIV infection., AIDS, 25, 1881, 10.1097/QAD.0b013e32834b4d48
Stevens, 2009, Measured GFR as a confirmatory test for estimated GFR., J Am Soc Nephrol, 20, 2305, 10.1681/ASN.2009020171
Lindblad, 1994, Comparative evaluation of iohexol and inulin clearance for glomerular filtration rate determinations., Acta Paediatr, 83, 418, 10.1111/j.1651-2227.1994.tb18133.x
Lundqvist, 1995, Experimental studies comparing iohexol and 51Cr-EDTA for glomerular filtration rate measurements., Acta Radiol, 36, 58, 10.1177/028418519503600110
Brown, 1991, Iohexol clearance for the determination of glomerular filtration rate in clinical practice: evidence for a new gold standard., J Urol, 146, 675, 10.1016/S0022-5347(17)37891-6
German, 2010, . Pharmacokinetics and bioavailability of an integrase and novel pharmacoenhancer-containing single-tablet fixed-dose combination regimen for the treatment of HIV., J Acquir Immune Defic Syndr, 55, 323, 10.1097/QAI.0b013e3181eb376b
Walser, 1998, Assessing renal function from creatinine measurements in adults with chronic renal failure., Am J Kidney Dis, 32, 23, 10.1053/ajkd.1998.v32.pm9669420
Masereeuw, 2010, Therapeutic implications of renal anionic drug transporters., Pharmacol Ther, 126, 200, 10.1016/j.pharmthera.2010.02.007
Wright, 2005, Role of organic cation transporters in the renal handling of therapeutic agents and xenobiotics., Toxicol Appl Pharmacol, 204, 309, 10.1016/j.taap.2004.10.021
Koepsell, 2007, Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications., Pharm Res, 24, 1227, 10.1007/s11095-007-9254-z
Berkhin, 2001, Regulation of renal tubular secretion of organic compounds., Kidney Int, 59, 17, 10.1046/j.1523-1755.2001.00461.x
Bonate, 1998, Drug interactions at the renal level. Implications for drug development., Clin Pharmacokinet, 34, 375, 10.2165/00003088-199834050-00004
Lepist, 2012, Renal drug-drug interactions: what we have learned and where we are going., Expert Opin Drug Metab Toxicol, 8, 433, 10.1517/17425255.2012.667401
Kremer, 1995, The effects of nonsteroidal antiinflammatory drugs on methotrexate (MTX) pharmacokinetics: impairment of renal clearance of MTX at weekly maintenance doses but not at 7.5 mg., J Rheumatol, 22, 2072
Abel, 2000, . Effect of cimetidine and ranitidine on pharmacokinetics and pharmacodynamics of a single dose of dofetilide., Br J Clin Pharmacol, 49, 64, 10.1046/j.1365-2125.2000.00114.x
Kosoglou, 1988, Trimethoprim alters the disposition of procainamide and N-acetylprocainamide., Clin Pharmacol Ther, 44, 467, 10.1038/clpt.1988.181
Tanihara, 2007, . Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusionsH()-organic cation antiporters., Biochem Pharmacol, 74, 359, 10.1016/j.bcp.2007.04.010
Urakami, 2004, . Creatinine transport by basolateral organic cation transporter hOCT2 in the human kidney., Pharm Res, 21, 976, 10.1023/B:PHAM.0000029286.45788.ad
Okuda, 2006, Interactions of fluoroquinolone antibacterials, DX-619 and levofloxacin, with creatinine transport by renal organic cation transporter hOCT2., Drug Metab Pharmacokinet, 21, 432, 10.2133/dmpk.21.432
Imamura, 2011, . Prediction of fluoroquinolone-induced elevation in serum creatinine levels: a case of drug-endogenous substance interaction involving the inhibition of renal secretion., Clin Pharmacol Ther, 89, 81, 10.1038/clpt.2010.232
Ray, 2006, . Mechanism of active renal tubular efflux of tenofovir., Antimicrob Agents Chemother, 50, 3297, 10.1128/AAC.00251-06
Ito, 2012, . Competitive inhibition of the luminal efflux by multidrug and toxin extrusions, but not basolateral uptake by organic cation transporter 2, is the likely mechanism underlying the pharmacokinetic drug-drug interactions caused by cimetidine in the kidney., J Pharmacol Exp Ther, 340, 393, 10.1124/jpet.111.184986
Ito, 2010, . Potent and specific inhibition of mMate1-mediated efflux of type I organic cations in the liver and kidney by pyrimethamine., J Pharmacol Exp Ther, 333, 341, 10.1124/jpet.109.163642
Tsuda, 2009, . Involvement of human multidrug and toxin extrusion 1 in the drug interaction between cimetidine and metformin in renal epithelial cells., J Pharmacol Exp Ther, 329, 185, 10.1124/jpet.108.147918